Peripheral neuropathy caused by chemotherapy in breast cancer patient
Conditions
Interventions
experimental group:cold therapy
control group:usual care
Sponsors
The Fourth Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The patient was diagnosed with breast cancer by pathology 2, female, age =18 years and age =80 years 3, good cooperation, can cooperate with the completion of various questionnaires 4, able to complete the complete chemotherapy program of 6 courses 5. Sign written informed consent
Exclusion criteria
Exclusion criteria: 1. Chemotherapy regimen containing oxaliplatin was adopted 2. Peripheral neuropathy has been caused by disease or other factors in the past 3, combined with rheumatoid arthritis, peripheral vascular disease 4. Patients with severe liver, kidney, heart and brain dysfunction, or serious complications 5. Patients with an expected survival of less than 6 months 6. Patients with stage IV breast cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACT/GOG-Ntx;EORTC-QLQ-CIPN20; | — |
Secondary
| Measure | Time frame |
|---|---|
| ADL;NRS;Hauser walking index; | — |
Countries
China
Contacts
Public ContactWu Danna
The Fourth Hospital of Hebei Medical University
Outcome results
None listed